|
Status |
Public on Jul 24, 2017 |
Title |
Characterization of three Epithelial Ovarian Cancer cell lines resistant to cisplatin (mRNA). |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by array
|
Summary |
Epithelial ovarian cancer (EOC) represents the gynecologic cancer with the highest mortality rate. Despite a high initial response to chemotherapy, the majority of patients with advanced EOC relapses and subsequently develops chemoresistance that results in treatment failure and death of the patient. AIM: we have generated an isogenic model of PT-resistance in a panel of 3 EOC cell lines. Gene Expression Profile (GEP) was used to identify new molecular pathawy that regulate chemoresistance.
|
|
|
Overall design |
GEP experiments were performed in 3 Epithelian Ovarian Cancer cell lines Platinum-resistant vs their parental, with Agilent platform. Bioinformatics analyses were performed by Gene Springs
|
|
|
Contributor(s) |
Sonego M, Pellizzari I, Bomben R, Baldassarre G |
Citation(s) |
28769043 |
|
Submission date |
Jan 18, 2017 |
Last update date |
Aug 25, 2019 |
Contact name |
Riccardo Bomben |
E-mail(s) |
rbomben@cro.it
|
Phone |
+39 0434 659718
|
Organization name |
CRO Aviano
|
Department |
D-RT
|
Lab |
Clinical and Experimental Onco Hematology Unit
|
Street address |
Via Franco Gallini 2
|
City |
Aviano |
ZIP/Postal code |
33080 |
Country |
Italy |
|
|
Platforms (1) |
GPL17077 |
Agilent-039494 SurePrint G3 Human GE v2 8x60K Microarray 039381 (Probe Name version) |
|
Samples (12)
|
|
This SubSeries is part of SuperSeries: |
GSE93795 |
Characterization of three Epithelial Ovarian Cancer cell lines resistant to cisplatin. |
|
Relations |
BioProject |
PRJNA362360 |